ANIXA BIOSCIENCES, INC. (ANIX) Current Ratio
- Current ratio · latest quarter: Value 8.54×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.54× | Current assets / current liabilities. $14.91M ÷ $1.75M ≈ 8.54× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 14.91M USD | Assets, Current |
| Current obligations | 1.75M USD | Liabilities, Current |
| Cash and equivalents | 1.40M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 282.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $14.91M | $1.75M | $1.40M | (m) | (m) | (m) | $282.00K | (m) | 8.54× |
| 2026-04-30 | $14.69M | $1.50M | $1.48M | (m) | (m) | (m) | $252.00K | (m) | 9.79× |
| 2026-01-31 | $15.05M | $1.24M | $1.55M | (m) | (m) | (m) | $148.00K | (m) | 12.18× |
| 2025-10-31 | $15.89M | $1.97M | $1.24M | (m) | (m) | (m) | $165.00K | (m) | 8.08× |
| 2025-07-31 | $17.45M | $2.07M | $1.50M | (m) | (m) | (m) | $276.00K | (m) | 8.45× |
| 2025-04-30 | $16.77M | $1.89M | $1.91M | (m) | (m) | (m) | $284.00K | (m) | 8.89× |
| 2025-01-31 | $18.69M | $2.00M | $1.05M | (m) | (m) | (m) | $600.00K | (m) | 9.35× |
| 2024-10-31 | $21.36M | $2.50M | $1.27M | (m) | (m) | (m) | $525.00K | (m) | 8.54× |
| 2024-07-31 | $22.67M | $2.00M | $1.23M | (m) | (m) | (m) | $302.00K | (m) | 11.31× |
| 2024-04-30 | $24.21M | $1.68M | $995.00K | (m) | (m) | (m) | $215.00K | (m) | 14.40× |
| 2024-01-31 | $25.22M | $1.66M | $998.00K | (m) | (m) | (m) | $364.00K | (m) | 15.19× |
| 2023-10-31 | $25.36M | $2.03M | $915.00K | (m) | (m) | (m) | $206.00K | (m) | 12.50× |
| 2023-07-31 | $26.40M | $1.86M | $3.20M | (m) | (m) | (m) | $94.00K | (m) | 14.22× |
| 2023-04-30 | $27.41M | $1.54M | $5.62M | (m) | (m) | (m) | $195.00K | (m) | 17.83× |
| 2023-01-31 | $28.11M | $1.23M | $9.79M | (m) | (m) | (m) | $110.00K | (m) | 22.81× |
| 2022-10-31 | $30.20M | $2.04M | $12.36M | (m) | (m) | (m) | $265.00K | (m) | 14.83× |
| 2022-07-31 | $32.34M | $1.47M | $24.25M | (m) | (m) | (m) | $227.00K | (m) | 22.01× |
| 2022-04-30 | $32.56M | $1.19M | $27.73M | (m) | (m) | (m) | $93.00K | (m) | 27.39× |
| 2022-01-31 | $34.99M | $1.79M | $29.78M | (m) | (m) | (m) | $504.00K | (m) | 19.58× |
| 2021-10-31 | $36.00M | $1.27M | $29.13M | (m) | (m) | (m) | $136.00K | (m) | 28.35× |
| 2021-07-31 | $37.05M | $1.21M | $27.22M | (m) | (m) | (m) | $207.73K | (m) | 30.67× |
| 2021-04-30 | $38.47M | $1.44M | $27.70M | (m) | (m) | (m) | $438.01K | (m) | 26.66× |
| 2021-01-31 | $14.56M | $1.53M | $11.98M | (m) | (m) | (m) | $511.82K | (m) | 9.55× |
| 2020-10-31 | $9.37M | $1.19M | $6.42M | (m) | (m) | (m) | $232.37K | (m) | 7.88× |
| 2020-07-31 | $9.26M | $1.21M | $5.93M | (m) | (m) | (m) | $339.30K | (m) | 7.64× |
| 2020-04-30 | $5.66M | $1.08M | $2.89M | (m) | (m) | (m) | $170.78K | (m) | 5.25× |
| 2020-01-31 | $5.87M | $1.13M | $2.82M | (m) | (m) | (m) | $367.10K | (m) | 5.21× |
| 2019-10-31 | $6.09M | $1.48M | $3.49M | (m) | (m) | (m) | $585.82K | (m) | 4.11× |
| 2019-07-31 | $6.63M | $1.44M | $4.40M | (m) | (m) | (m) | $567.78K | (m) | 4.59× |
| 2019-04-30 | $7.49M | $1.60M | $3.82M | (m) | (m) | (m) | $717.92K | (m) | 4.70× |
| 2019-01-31 | $6.24M | $1.33M | $4.15M | (m) | (m) | (m) | $612.94K | (m) | 4.70× |
| 2018-10-31 | $5.54M | $1.27M | $3.06M | (m) | (m) | (m) | $582.01K | (m) | 4.38× |
| 2018-07-31 | $5.72M | $1.13M | $2.59M | (m) | (m) | (m) | $419.41K | (m) | 5.06× |
| 2018-04-30 | $5.72M | $1.34M | $4.17M | (m) | (m) | (m) | $452.11K | (m) | 4.27× |
| 2018-01-31 | $5.78M | $1.09M | $2.85M | (m) | (m) | (m) | $416.93K | (m) | 5.32× |
| 2017-10-31 | $7.01M | $889.49K | $3.34M | (m) | (m) | (m) | $480.32K | (m) | 7.89× |
| 2017-07-31 | $6.45M | $2.93M | $1.83M | (m) | $221.05K | (m) | $444.75K | (m) | 2.20× |
| 2017-04-30 | $5.19M | $3.66M | $2.88M | (m) | (m) | (m) | $448.35K | (m) | 1.42× |
| 2017-01-31 | $2.07M | $3.72M | $1.40M | (m) | (m) | (m) | $540.68K | (m) | 0.56× |
| 2016-10-31 | $3.40M | $468.76K | $2.49M | (m) | (m) | (m) | $373.22K | (m) | 7.25× |
| 2016-07-31 | $4.01M | $531.62K | $2.05M | (m) | (m) | (m) | $444.82K | (m) | 7.53× |
| 2016-04-30 | $4.80M | $706.93K | $2.61M | (m) | (m) | (m) | $418.11K | (m) | 6.79× |
| 2016-01-31 | $6.19M | $1.24M | $3.98M | (m) | (m) | (m) | $560.41K | (m) | 4.97× |
| 2015-10-31 | $6.90M | $593.78K | $4.37M | (m) | (m) | (m) | $374.70K | (m) | 11.61× |
| 2015-07-31 | $7.75M | $711.67K | $5.16M | (m) | (m) | (m) | $424.69K | (m) | 10.90× |
| 2015-04-30 | $8.52M | $688.68K | $6.08M | (m) | (m) | (m) | $388.79K | (m) | 12.38× |
| 2015-01-31 | $10.57M | $1.67M | $7.81M | (m) | $45.00K | (m) | $577.61K | (m) | 6.34× |
| 2014-10-31 | $6.32M | $1.81M | $3.36M | (m) | $400.00K | (m) | $540.18K | (m) | 3.49× |
| 2014-07-31 | $6.44M | $8.36M | $3.65M | (m) | $133.33K | (m) | $529.34K | (m) | 0.77× |
| 2014-04-30 | $3.63M | $10.68M | $617.72K | (m) | $828.37K | (m) | $457.76K | (m) | 0.34× |
| 2014-01-31 | $3.37M | $11.55M | $776.14K | (m) | (m) | (m) | $491.77K | (m) | 0.29× |
| 2013-10-31 | $1.23M | $3.21M | $898.17K | (m) | $175.00K | (m) | $527.21K | (m) | 0.38× |
| 2013-07-31 | $1.03M | $3.09M | $982.03K | (m) | (m) | (m) | $516.04K | (m) | 0.33× |
| 2013-04-30 | $1.33M | $3.30M | $1.27M | (m) | (m) | (m) | $534.05K | (m) | 0.40× |
| 2013-01-31 | $1.78M | $3.44M | $1.71M | (m) | (m) | (m) | $489.22K | (m) | 0.52× |
| 2012-10-31 | $922.02K | $1.82M | $339.69K | (m) | (m) | (m) | $304.52K | (m) | 0.51× |
| 2012-07-31 | $1.14M | $1.78M | $101.53K | (m) | (m) | (m) | $462.86K | (m) | 0.64× |
| 2012-04-30 | $1.79M | $2.13M | $130.73K | (m) | (m) | (m) | $558.74K | (m) | 0.84× |
| 2012-01-31 | $2.61M | $2.06M | $463.04K | (m) | (m) | (m) | $449.14K | (m) | 1.27× |
| 2011-10-31 | $3.12M | $2.11M | $774.04K | (m) | (m) | (m) | $374.69K | (m) | 1.48× |
| 2011-07-31 | $3.64M | $2.93M | $551.40K | (m) | (m) | $33.36K | $278.41K | (m) | 1.24× |
| 2010-10-31 | $1.23M | $450.12K | $1.09M | (m) | (m) | (m) | $355.68K | (m) | 2.74× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |